Point72 Asset Management
CNTA

Point72 Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Point72 Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Buy
+307,355
New +$7.86M 0.02% 1107
2025
Q4 		– Sell
-1,072,665
Closed -$26M – 3940
2025
Q3 		$26M Sell
1,072,665
-1,518,931
-59% -$27M 0.04% 465
2025
Q2 		$34.1M Buy
2,591,596
+305,163
+13% +$3.87M 0.07% 332
2025
Q1 		$32.9M Sell
2,286,433
-1,140,166
-33% -$18.7M 0.08% 312
2024
Q4 		$57.4M Buy
3,426,599
+710,936
+26% +$11.8M 0.13% 189
2024
Q3 		$43.4M Buy
2,715,663
+953,659
+54% +$11.7M 0.11% 214
2024
Q2 		$15.9M Sell
1,762,004
-495,714
-22% -$4.7M 0.04% 457
2024
Q1 		$25.5M Buy
2,257,718
+417,236
+23% +$3.95M 0.06% 371
2023
Q4 		$14.7M Hold
1,840,482
– – 0.04% 551
2023
Q3 		$11.9M Sell
1,840,482
-170,906
-8% -$1.17M 0.03% 585
2023
Q2 		$12.5M Buy
2,011,388
+235,906
+13% +$1.12M 0.04% 523
2023
Q1 		$6.84M Buy
1,775,482
+1,695,782
+2,128% +$6.2M 0.02% 668
2022
Q4 		$247K Sell
79,700
-38,100
-32% -$141K ﹤0.01% 1237
2022
Q3 		$474K Sell
117,800
-15,800
-12% -$72.3K ﹤0.01% 1177
2022
Q2 		$651K Sell
133,600
-773,400
-85% -$4.95M ﹤0.01% 1150
2022
Q1 		$8.14M Sell
907,000
-190,908
-17% -$1.74M 0.03% 572
2021
Q4 		$12.4M Buy
1,097,908
+795,708
+263% +$10.7M 0.05% 452
2021
Q3 		$5.05M Buy
302,200
+202,200
+202% +$4.18M 0.02% 661
2021
Q2 		$2.22M Buy
+100,000
New +$2.35M 0.01% 720

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Point72 Asset Management's CNTA Position: Q1 2026 in Review

Point72 Asset Management opened a new position in Centessa Pharmaceuticals (CNTA) in Q1 2026: 307,355 shares worth $12.2M. The stake represents 0.02% of the portfolio and ranks #1107 among its holdings. This is a return to the name: Point72 Asset Management previously reported a position in CNTA as recently as Q3 2025.

Point72 Asset Management first reported a position in CNTA in Q2 2021 and has held it in 19 quarters since. The position peaked at $57.4M in Q4 2024. 161 funds tracked by Wall St. Rank hold CNTA as of Q1 2026.

  • Point72 Asset Management held 307,355 shares of Centessa Pharmaceuticals worth $12.2M as of Q1 2026.
  • Centessa Pharmaceuticals was a new Point72 Asset Management position in Q1 2026.
  • Centessa Pharmaceuticals made up 0.02% of Point72 Asset Management's portfolio in Q1 2026, its #1107 holding.
  • Point72 Asset Management first reported a position in Centessa Pharmaceuticals in Q2 2021 and has held it in 19 quarters since.
  • Point72 Asset Management's Centessa Pharmaceuticals position peaked at $57.4M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.